Immunogenic cell stress and death in the treatment of cancer
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Developmental Biology
Reference199 articles.
1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
2. Immune checkpoint therapy-current perspectives and future directions;Sharma;Cell,2023
3. Immune checkpoint blockade across the cancer care continuum;Helmink;Immunity,2018
4. The anticancer immune response: indispensable for therapeutic success?;Zitvogel;J. Clin. Invest,2008
5. Neoadjuvant immunotherapy for melanoma is now ready for clinical practice;Garbe;Nat. Med,2023
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Doxorubicin-induced Immunogenic Cell Death Impairs Tumor Progression and Distant Metastasis in a 4T1 Breast Cancer Tumor Model;Current Pharmaceutical Design;2024-09
2. Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination;Cancer Letters;2024-08
3. Editorial: Special issue SCDB “Cell death and survival”;Seminars in Cell & Developmental Biology;2024-04
4. Inhibiting autophagy enhanced mitotic catastrophe-mediated anticancer immune responses by regulating the cGAS-STING pathway;Cancer Letters;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3